Home Medicine Odontoiatric perspectives and osteonecrosis of the jaw as a possible adverse effect of bisphosphonates therapy in fibrous dysplasia and McCune-Albright syndrome
Article
Licensed
Unlicensed Requires Authentication

Odontoiatric perspectives and osteonecrosis of the jaw as a possible adverse effect of bisphosphonates therapy in fibrous dysplasia and McCune-Albright syndrome

  • Daniele Tessaris EMAIL logo , Patrizia Matarazzo , Roberto Lala and Patrizia Defabianis
Published/Copyright: November 13, 2015

Abstract

Background: McCune-Albright syndrome (MAS) is characterized by the triad of polyostotic bone fibrous dysplasia (PFD), endocrine disorders, and café-au-lait skin pigmentation. Ninety percent of MAS patients have fibrous dysplasia (FD) craniofacial lesions. Osteonecrosis of the jaw (ONJ) has been described as an adverse side effect of bisphosphonate therapy. The aim of the study was to investigate evidence of clinical and/or radiological signs of ONJ in FD/MAS pediatric patients due to bisphosphonate therapy and describe odontoiatric tools in this population.

Methods: Thirteen FD/MAS patients were enrolled. All patients during pediatric age have been treated with pamidronate infusions. They underwent complete oral clinical examination. Ortopantomography and/or CT were evaluated in all cases.

Results and conclusions: No patient developed ONJ. None of them showed radiological signs different from jaw FD. In spite of the low number of patients enrolled, results confirm that, in this population, ONJ can be ruled out as a chronic adverse side effect of bisphosphonate therapy.


Corresponding author: Daniele Tessaris, MD, Department of Pediatric Endocrinology and Diabetology, University of Turin, Regina Margherita Children Hospital, Piazza Polonia 94, 10126, Turin, Italy, Phone: +39-011-313-1790, Fax: +39-011-313-5357, E-mail:

References

1. Dumitrescu CE, Collins MT. McCune-Albright syndrome. Orphanet J Rare Dis 2008;19:3–12.Search in Google Scholar

2. Mauras N, Blizzard RM. The McCune-Albright syndrome. Acta Endocrinol 1986;(Suppl 279):207–17.10.1530/acta.0.112S207Search in Google Scholar

3. Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, et al. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr 1993;123:509–18.10.1016/S0022-3476(05)80943-6Search in Google Scholar

4. Lala R, Matarazzo P, Andreo M, Defilippi C, de Sanctis C. Impact of endocrine hyperfunction and phosphate wasting on bone in McCune-Albright syndrome. J Pediatr Endocrinol Metab 2002;15(Suppl 3):913–20.Search in Google Scholar

5. Riminucci M, Robey PG, Bianco P. The pathology of fibrous dysplasia and the McCune-Albright syndrome. Pediatr Endocrinol Rev 2007;4(Suppl 4):401–11.Search in Google Scholar

6. Defilippi C, Chiappetta D, Marzari D, Mussa A, Lala R. Image diagnosis in McCune-Albright syndrome. J Pediatr Endocrinol Metab 2006;19(Suppl 2):561–70.10.1515/JPEM.2006.19.S2.561Search in Google Scholar

7. Sontakke SA, Karjodkar FR, Umarji HR. Computed tomographic features of fibrous dysplasia of maxillofacial region. Imaging Sci Dent 2011;41:23–8.10.5624/isd.2011.41.1.23Search in Google Scholar

8. Steven RS, Muralidhar M, Joseph R. Clinical and radiographic features of chronic monostotic fibrous dysplasia of the mandible. J Can Dent Assoc 2004;70:548–52.Search in Google Scholar

9. Akintoye SO, Boyce AM, Collins MT. Dental perspectives in fibrous dysplasia and McCune-Albright syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:149–55.10.1016/j.oooo.2013.05.023Search in Google Scholar

10. Catena DL, Glick GL. Monostotic fibrous dysplasia with dental anomalies. Report of a case. Oral Surg Oral Med Oral Pathol 1971;32(Suppl 1):136–40.10.1016/0030-4220(71)90259-3Search in Google Scholar

11. Esposito SJ, Gabriel L, Smith JD, Zins JE. Fibrous dysplasia: a case report. Compend Contin Educ Dent 1995;16(Suppl 7): 652.Search in Google Scholar

12. Lala R, Matarazzo P, Andreo M, Marzari D, Bellone J, et al. Study group for Gs alpha protein related diseases of the italian society for pediatric endocrinology and diabetes. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome. J Pediatr Endocrinol Metab 2006;19(Suppl 2):583–93.10.1515/JPEM.2006.19.S2.583Search in Google Scholar

13. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61(Suppl 9):1115–7.10.1016/S0278-2391(03)00720-1Search in Google Scholar

14. Ruggiero S. Bisphosphonates complication including osteonecrosis of the jaw. Hematology 2006;515:356–60.Search in Google Scholar

15. Dumitrescu CE, Collins MT. McCune-Albright syndrome. Orphanet J Rare Dis 2008;19:3–12.Search in Google Scholar

16. Gómez Font R, Martínez García ML, Olmos Martínez JM. Osteochemonecrosis of the jaws due to bisphosphonate treatments. Update Med Oral Patol Oral Cir Bucal 2008;13:E318–24.Search in Google Scholar

17. Bartl R. Biologic half-life of bisphosphonates. Dtsch Med Wochenschr 2009;134:651–2.10.1055/s-0029-1208102Search in Google Scholar PubMed

18. Aravinda K, Ratnakar P, Srinivas K. Oral manifestations of McCune-Albright syndrome. Indian J Endocrinol Metab 2013;17:170–3.10.4103/2230-8210.107878Search in Google Scholar PubMed PubMed Central

19. Akintoye SO, Lee JS, Feimster T, Booher S, Brahim J, et al. Dental characteristics of fibrous dysplasia and McCune-Albright syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:275–82.10.1016/S1079-2104(03)00225-7Search in Google Scholar

Received: 2015-7-23
Accepted: 2015-9-30
Published Online: 2015-11-13
Published in Print: 2016-3-1

©2016 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Role of nutrition in preventing insulin resistance in children
  4. Original Articles
  5. Reduced frequency and severity of ketoacidosis at diagnosis of childhood type 1 diabetes in Northwest Saudi Arabia
  6. Differences in parental involvement in the care of children and adolescents with type 1 diabetes mellitus on multiple daily insulin injections versus continuous subcutaneous insulin infusion
  7. Value of the intrarenal arterial resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients
  8. Remission of congenital hyperinsulinism following conservative treatment: an exploratory study in patients with KATP channel mutations
  9. Relationship between visceral obesity and plasma fibrinogen in obese children
  10. Diagnostic approach in children with unusual symptoms of acquired hypothyroidism. When to look for pituitary hyperplasia?
  11. The shortened combined clonidine and arginine test for growth hormone deficiency is practical and specific: a diagnostic accuracy study
  12. Bone maturation along the spectrum from normal weight to obesity: a complex interplay of sex, growth factors and weight gain
  13. Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves’ disease
  14. Direct sequencing of FAH gene in Pakistani tyrosinemia type 1 families reveals a novel mutation
  15. Odontoiatric perspectives and osteonecrosis of the jaw as a possible adverse effect of bisphosphonates therapy in fibrous dysplasia and McCune-Albright syndrome
  16. The relation of urinary bisphenol A with kisspeptin in girls diagnosed with central precocious puberty and premature thelarche
  17. Pattern of teen menstruation among secondary school girls in south east Nigeria
  18. Should children with isolated premature adrenarche be routinely evaluated for non-classical congenital adrenal hyperplasia?
  19. Anxiety, depression and self-esteem levels in obese children: a case-control study
  20. Case Reports
  21. Transient congenital hypothyroidism caused by compound heterozygous mutations affecting the NADPH-oxidase domain of DUOX2
  22. Isolated methylmalonic acidemia with unusual presentation mimicking diabetic ketoacidosis
  23. A first case report of UDP-galactose-4′-epimerase deficiency in China: genotype and phenotype
  24. A novel mutation in the glutamate dehydrogenase (GLUD1) of a patient with congenital hyperinsulinism-hyperammonemia (HI/HA)
  25. Letter to the Editor
  26. Partial biotinidase deficiency: identification of a single novel mutation (p.H314R) in a Greek newborn
Downloaded on 18.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0300/pdf
Scroll to top button